Director, IHV Clinical Community Health Programs; Director, IHV Clinical Innovation Programs
Director, Baltimore VA Hospital HIV Care and Infectious Diseases Clinic
Education and Training
Fellowship Infectious Disease
University of Maryland School of Medicine, Baltimore, MD
Residency Internal Medicine
Tufts University School of Medicine, New England Medical Center, Boston, MA
Medical College of Georgia
Georgia Institute of Technology
I am an Associate Professor of Medicine at the Institute of Human Virology at the University of Maryland.
I am highly involved in clinical care and out comes research both domestically as well as internationally in both HIV and infections associated with immuncompormised patients, particularly those with solid organ transplantations.
My particular research interests center on improving viral suppression rate of first line antiretroviral therapy in difficult to treat populations. I have focused on both therapeutic strategies, including augmented therapies for HIV as well as HIV clinical care delivery as it pertains to improving adherence and suppression in underprivileged populations.
I have also dedicated my career in HIV and Infectious Disease education establishing and directing the major outpatient-training program for the UMSOM ID division as the Section Chief for the Baltimore VA Infectious Diseases Division. My international experience is extensive through PEPFAR grants starting in 2004, developing models of sustainable HIV care delivery in both rural and urban Guyana, Haiti, Kenya, Nigeria, Rwanda, Tanzania, and Uganda in the highly successful AIDSRelief Program.
In addition I have a strong interest in infectous diseases associated with solid organ transplantation, with particular focus on HIV and transplantation and viral infections of this population. I have dedicated time to further expanding the expertise in transplant infectious diesease at the UMMC. Currently we are working on a collaborative HOPE protocol for HIV organ donation.
Ramay FH, Amoroso A, von Rosenvinge EC, Saharia K. Fecal Microbiota Transplantation for Treatment of Severe, Recurrent, and Refractory Clostridium difficile Infection in a Severely Immunocompromised Patient. Infectious Diseases in Clinical Practice: July 2016 - Volume 24 - Issue 4 - p 237–240 doi: 10.1097/IPC.0000000000000338Jun 7.
Husson J, Saleeb P, Amoroso A. Mycobacterium abscessus: The Implications of Misidentification in the Immunocompromised Host. Infectious Diseases in Clinical Practice. February 16, 2016 doi: 10.1097/IPC.00000000000003852016
Heil EL, Shah KP, Amoroso A. Successful Salvage Therapy Using Daptomycin and Ceftaroline After the Emergence of Daptomycin Nonsusceptible Staphylococcus aureus Endocarditis and Infected Pacemaker/Implantable Cardioverter-Defibrillator. Infectious Diseases in Clinical Practice. 2015 May 1;23(3):155-7.
Macharia T, Amoroso A, Mesubi ME, Edozien A. Antiretroviral Toxicity Leading to a Medication Change in Multiple HIV Clinics in Resource Limited Settings. J Antivir Antiretrovir. 2014;6:139-47.
Osinusi-Adekanmbi O, Stafford K, Ukpaka A, Salami D, Ajayi S, Ndembi N, Abimiku AL, Nwizu C, Gilliam B, Redfield R, Amoroso A. Long-Term Outcome of Second-Line Antiretroviral Therapy in Resource-Limited Settings. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2014 Jul 1;13(4):366-71.
Infetions in solid organ transplantation.
The treatment of endocarditis.
HIV care and treatment.
HIV care and treatment after solid organ transplantation.